Metastatic breast cancer in Brazil: characterization of patients and treatments.
Type of Study: Epidemiological
Sponsor / Support: LACOG, Novartis
Primary Objectives: To describe patients demographics and socioeconomic characteristics and to describe the BC pathological characterization.
Design: All patients diagnosed with de novo or recurrent MBC from January 2012 to December 2012 at participating centers will be included. Data will be collected in selected LACOG centers (N=15-20) comprising different regions in Brazil. Availability of tumor samples (FFPE) stored in the center will be registered for a possible future translational research.
Sample Size: 500 to 1500 patients
Principal Investigator: Carlos Barrios
LACOG 1518 – Bladder Cancer Registry
LACOG 0515 – Testicular Registry
LACOG 0217 – IRONMAN
LACOG 1818 – Prostate Cancer Registry
LACOG 0218 – Hercules
LACOG 0415 – APA in Prostate Cancer
LACOG 0519 – PEACE III